Costly Information in Firm Transformation, Exit, or Persistent Failure
Firms invest differentially in the intellectual human capital required to recognize, evaluate, and utilize technological breakthroughs occurring outside the firm. Such differential investment has been crucial in explaining which incumbent pharmaceutical firms have successfully transformed their technological identities in response to the biotechnological revolution and which are threatened by persistent low performance. While all incumbent firms lagged the dedicated new biotechnology firms in adopting the new drug-discovery technology, firms with higher R&D expenditures before the biotech revolution were more likely to successfully adopt the new techniques and likely to do so earlier. Failure to adopt the new techniques was associated with lower performance compared to firms adopting more fully and faster.
|Date of creation:||May 1996|
|Publication status:||published as American Behavioral Scientist, vol. 39, no. 8, August 1996.|
|Contact details of provider:|| Postal: National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.|
Web page: http://www.nber.org
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Zucker, Lynne G. & Brewer, Marilynn B. & Darby, Michael R. & Peng, Yusheng, 1994.
"Collaboration Structure and Information Dilemmas in Biotechnology: Organizational Boundaries as Trust Production,"
Institute for Social Science Research, Working Paper Series
qt0gd8j9k8, Institute for Social Science Research, UCLA.
- Lynne G. Zucker & Michael R. Darby & Marilynn B. Brewer & Yusheng Peng, 1995. "Collaboration Structure and Information Dilemmas in Biotechnology: Organizational Boundaries as Trust Production," NBER Working Papers 5199, National Bureau of Economic Research, Inc.
- Hanson, Gordon H, 1995. "Incomplete Contracts, Risk, and Ownership," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 36(2), pages 341-363, May.
- Patricia M. Danzon & Allison Percy, 1999. "The Effects of Price Regulation on Productivity in Pharmaceuticals," NBER Chapters,in: International and Interarea Comparisons of Income, Output, and Prices, pages 371-418 National Bureau of Economic Research, Inc.
- Darby, Michael R, 1976. "Rational Expectations under Conditions of Costly Information," Journal of Finance, American Finance Association, vol. 31(3), pages 889-895, June.
- Michael R. Darby, 1974. "Rational Expectations Under Conditions of Costly Information," UCLA Economics Working Papers 045, UCLA Department of Economics.
- Lynne G. Zucker & Michael R. Darby & Jeff Armstrong, 1994. "Intellectual Capital and the Firm: The Technology of Geographically Localized Knowledge Spillovers," NBER Working Papers 4946, National Bureau of Economic Research, Inc.
- Lynne G. Zucker & Michael R. Darby, 1995. "Present at the Revolution: Transformation of Technical Identity for a Large Incumbent Pharmaceutical Firm After the Biotechnological Breakthrough," NBER Working Papers 5243, National Bureau of Economic Research, Inc.
- Zucker, Lynne G & Darby, Michael R & Brewer, Marilynn B, 1998. "Intellectual Human Capital and the Birth of U.S. Biotechnology Enterprises," American Economic Review, American Economic Association, vol. 88(1), pages 290-306, March. Full references (including those not matched with items on IDEAS)